Doximity Inc(DOCS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:00 PM ET (Korea 10/27 05:00)
Full metrics table
| Index | - | P/E | 39.23 | EPS (ttm) | 0.84 | Insider Own | 31.26% | Shs Outstand | 128.9M | Perf Week | 5.18% |
| Market Cap | 5.90B | Forward P/E | 21.23 | EPS next Y | 15.68% | Insider Trans | -0.07% | Shs Float | 122.5M | Perf Month | 25.54% |
| Enterprise Value | 5.22B | PEG | 3.06 | EPS next Q | 0.35 | Inst Own | 73.31% | Short Float | 9.21% | Perf Quarter | 54.29% |
| Income | 0.17B | P/S | 8.99 | EPS this Y | -11.4% | Inst Trans | 1.72% | Short Ratio | 2.5 | Perf Half Y | 34.14% |
| Sales | 0.66B | P/B | 6.49 | EPS next 5Y | 6.93% | ROA | 14.6% | Short Interest | 11.28M | Perf YTD | -25.29% |
| Book/sh | 5.09 | P/C | 8.57 | EPS past 3/5Y | 23.05% 52.71% | ROE | 17.21% | 52W High | -53.65% ($71.37) | Perf Year | -50.51% |
| Cash/sh | 3.86 | P/FCF | 19.85 | Sales past 3/5Y | 15.45% 25.53% | ROIC | 18.09% | 52W Low | 92.89% ($17.15) | Perf 3Y | 57.08% |
| Dividend Est. | - | EV/EBITDA | 23.66 | EPS Y/Y TTM | -28.59% | Gross Margin | 87.41% | Volatility(W/M) | 3.64% 4.34% | Perf 5Y | -50.23% |
| Dividend TTM | - | EV/Sales | 7.96 | Sales Y/Y TTM | 11.18% | Oper. Margin | 30.57% | ATR (14) | 1.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.04 | EPS Q/Q | -52.02% | Profit Margin | 25.48% | RSI (14) | 69.74 | Recom | 2.48 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.04 | Sales Q/Q | 7.34% | SMA20 | 8.94% ($30.37) | Beta | 1.3 | Target Price | $31.05 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/11/5 | SMA50 | 19.69% ($27.64) | Rel Volume | 0.44 | Prev Close | $33.39 |
| Employees | 880 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -4.26% 3.19% | SMA200 | 28.59% ($25.73) | Avg Volume(3M) | 4.51M | Price | $33.08 |
| IPO | 2021/6/24 | Option/Short | Yes/Yes | Trades | 17636 | Volume | 1,962,209 | Change | -0.93% |
A healthcare technology company that operates a digital platform for medical professionals. It offers a professional network for physicians and other medical professionals, digital marketing services for pharmaceutical companies, and telehealth tools, with strengths in its extensive medical professional network and high profitability. The company operates in the medical professional platform sector.
Over the past 1 year, roughly in the middle
54% below its 1-year high.
Traded less than usual. That is 44% of its average volume.
Next earnings report: November 5
10 days to go.
DOCS makes money exceptionally well
Of every $100 in sales, $30.57 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -11.4% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $2,123. Peers typically go for $2,143. Compared with its own 5-year average, it is 19% cheaper now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -50.2%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 73.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #6 of 41 in the industry
Based on market cap of $6B.
HNGE#4 Hinge Health Inc $9B PER 86.0 
HQY#5 Healthequity Inc $9B PER 37.5 DOCS#6 Doximity Inc $6B PER 39.2 
WAY#7 Waystar Holding Corp $5B PER 40.8 
HTFL#8 Heartflow Inc $5B PER - 
FAQ
What kind of company is DOCS?
DOCS belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of DOCS?
The market cap of DOCS is approximately $5.9B, ranking 1,221 within its sector.
What is the P/E ratio of DOCS?
DOCS has a P/E ratio of approximately 39.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DOCS?
DOCS has recorded a 52-week high of $71.37 and a low of $17.15.
